SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is currently trending following news of a U.S. Air Force contract to advance swarming capabilities and a significant increase to its 2026 revenue guidance. The community is actively discussing the company's position in the defense AI sector, with many anticipating a potential short squeeze due to high short interest, though some note the absence of specific contract value details.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is a highly debated stock, trending due to recent analyst downgrades ahead of its anticipated earnings report. While many investors express deep frustration over persistent price declines and perceived market manipulation, others view its current valuation as a compelling 'no-brainer' buying opportunity, citing strong fundamentals and strategic moves into AI commerce and international partnerships. The community is sharply divided between calling it 'PainPal' and believing a significant rebound is imminent as market sentiment eventually shifts.

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

GRI Bio Inc. is trending following positive Phase 2a clinical data for its IPF treatment and a recent 1-for-28 reverse stock split, which has created an exceptionally low float of approximately 500k shares. The community is sharply divided; many anticipate a significant short squeeze comparing it to prior low-float runners, while others express deep skepticism citing the company's history of frequent dilutions and management's perceived lack of trustworthiness. This ongoing debate fuels significant volatility as investors weigh scientific progress against past financial actions.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is actively discussed after its recent financial results indicated accelerated sales and positive guidance, triggering upward movement and generating buzz about a potential short squeeze. Community sentiment is divided, with many celebrating a perceived turnaround, while others express caution regarding persistent margin pressures, ongoing labor disputes, and intensifying competition.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is a trending topic amidst news of significant corporate layoffs and an internal communication misstep, with community sentiment largely viewing these cuts as a strategic move toward greater efficiency and AI integration. This coincides with a shift in its grocery strategy, focusing on online delivery and Whole Foods expansion, while a recently awarded government contract and reports of notable insider buying further fuel discussion around the stock's future trajectory.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is trending after securing a $75 million direct offering from a new institutional investor to fund its Phase 3 MASH trial, coinciding with Barclays initiating coverage with an 'Overweight' rating and a $20 price target. Despite initial market reaction to the offering price, the community views this as a strategic de-risking move that bolsters the company's negotiating position for a potential partnership or acquisition, leveraging its Breakthrough Therapy Designated pemvidutide in the competitive MASH market.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending due to record order intake and strong long-term guidance, driven by accelerating AI-related demand and increased capital expenditure plans from major chipmakers. The community is actively discussing ASML's critical role as the backbone of advanced chipmaking and its unique EUV monopoly, solidifying its position as a key beneficiary of the structural AI infrastructure buildout. While many highlight the strong demand converting AI capex into hard orders, some also question the stock's valuation after a significant run.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending due to circulating reports of a potential merger with Automation Anywhere, which has ignited varied community reactions. This news, coupled with significant new contracts from the U.S. Army and Department of Health and Human Services, is fueling intense speculation about a potential short squeeze given the stock's high short interest and its enterprise AI market position.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics Inc. is trending due to a new collaboration with Microsoft AI Co-Innovation Labs, aiming to integrate advanced agentic AI capabilities into its robotics, a development that has ignited widespread enthusiasm across the AI and robotics sector. This partnership is viewed by many as a significant validation, though some community discussions also center on a recent private placement offering, with opinions split between it being a bullish institutional investment or a concern for dilution. The strong reaction indicates a lively debate among investors regarding the company's future trajectory.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is trending following a strong fourth-quarter earnings report that surpassed expectations and provided a bullish multi-year outlook. The community is actively discussing the company's commitment to return capital to shareholders through significant buybacks and dividends, alongside continued growth in its crucial fiber and 5G businesses. Investors view AT&T as a compelling value and a defensive play, despite competitive pressures, fueled by optimism around its strategic investments in advanced connectivity and satellite partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HSBC heads up at $80.89: Golden Genesis fib should give us a DIP - #HSBC TradingView https://www.tradingview.com/chart/HSBC/79uad6I0-HSBC-heads-up-at-80-89-Golden-Genesis-fib-should-give-us-a-DIP/

EuroMotif

HSBC grinding upwards along with all financials. It is about to hit a Golden Genesis fib at $80.89 Look for a Dip-to-Fib or a Break-n-Retest to join. . Previous analysis that caught the PERFECT BOTTOM: https://www.tradingview.com/chart/HSBC/u8UeB1LJ-HSBC-eyes-on-44-xx-Major-Support-that-could-launch-next-leg/ And subsequent call for CONTINUATION of uptrend: https://www.tradingview.com/chart/HSBC/dn64rNAE-HSBC-eyes-on-53-xx-Key-Resistance-to-recovery-of-UpTrend/ .

TradingView

HSBC heads up at $80.89: Golden Genesis fib should give us a DIP for NYSE:HSBC by EuroMotif

StockTwits Web

HSBC Holdings plc

 heads up at $80.89: Golden Genesis fib should give us a DIP - 